Plenary Session 4: Closing Ceremony
Saturday, August 3, 2024 |
3:00 PM - 4:10 PM |
Auditorium 2 |
Speaker
Dr. Evan Cunningham
Research Fellow, Viral Hepatitis and Clinical Research Program
Kirby Institute
Dr Alyssa Fitzpatrick
Infectious Diseases Physician
Women's And Children's Hospital, Adelaide
Clinical Science Rapporteur
3:10 PM - 3:20 PMBiography
Dr Alyssa Fitzpatrick is an Infectious Diseases Physician based in Adelaide, Australia. She has an interest in tropical medicine and obstetric and perinatal infectious disease, and recently completed her last six months of registrar training at the Royal Darwin Hospital in 2023.
Dr Jacqui Richmond
Nurse Educator
Burnet Institute
Models of Care & Programs Rapporteur
3:20 PM - 3:30 PMBiography
Jacqui is a registered nurse and completed a PhD in 2006. She currently works at the Barwon Public Health Unit as the Viral Hepatitis Clinical Nurse Consultant and at the Burnet Institute in the Eliminate hepatitis C Australia partnership.
Mr Edan Campbell-O'Brien
Aboriginal And Torres Strait Islander Lead
ASHM Health
Social Science & Policy Rapporteur
3:30 PM - 3:40 PMBiography
Edan is a proud Murri and Yulluna man from North-West QLD and proud Polynesian from the Cook Islands. Edan is passionate about advancing health outcomes for Aboriginal and Torres Strait Islander people and leads ASHM's Aboriginal and Torres Strait Islander portfolio as the organisations Indigenous Health Engagement Advisor.
Ms Emily Lenton
Research Officer
La Trobe
Social Science & Policy Rapporteur
3:30 PM - 3:40 PMBiography
Emily Lenton is a Research and Project Officer at the Australian Research Centre in Sex, Health and Society, La Trobe University, working on the design and implementation of qualitative projects that seek to improve the lives of people affected by BBV/STIs.
Mr Darryl O'Donnell
Interim CEO
Hepatitis Australia
Community Closing
3:40 PM - 3:50 PMBiography
Adjunct Professor Darryl O’Donnell is the Interim CEO of Hepatitis Australia. A seasoned and well respected health leader with more than 30 years’ experience in community, research and public sector roles, Darryl has led transformative initiatives in blood-borne viruses and mental health across government and community sectors.
He is a passionate consumer advocate, serving on the Board of the Consumers Health Forum of Australia and driving reforms to research governance and administration through the National Health and Medical Research Council.
He is also a Fellow of the Governance Institute of Australia and a graduate of the Australian Institute of Company Directors.
Dr Kelly Hosking
Director of Sexual Health Blood Borne Viruses
NT Health & Menzies School of Health Research
Committee Closing Remarks
3:50 PM - 4:00 PMBiography
Kelly is the Director of Sexual Health and Blood Borne Viruses for Northern Territory (NT) Health. Her PhD research aims to eliminate CHB in the Aboriginal and Torres Strait Islander people in the NT and focuses on improving clinical care, systems and health education.
Ms Jessica Michaels
Deputy CEO
ASHM Health
ASHM Closing Remarks
4:00 PM - 4:05 PMBiography
Jessica Michaels is the Deputy CEO at ASHM. Jessicas work at ASHM includes overseeing the implementation of HIV, sexual health, hepatitis C and hepatitis B workforce development, capacity building, resources, strategies and policies across Australia. Jessica has worked in the BBV and sexual health sector for over 15 years, managing a variety of government and non-government education, clinical and health promotion programs in Australia, South Africa, the UK, Papua New Guinea and Singapore.
2025 VH Conference Convenors
Conference Announcement
4:05 PM - 4:10 PMBiography
Chairperson
Benjamin Cowie
Director
WHO CC for Viral Hepatitis
Kelly Hosking
Director of Sexual Health Blood Borne Viruses
NT Health & Menzies School of Health Research